Ziqiang Yuan Selected Research

Adenocarcinoma

1/2018	Development of a Method to Implement Whole-Genome Bisulfite Sequencing of cfDNA from Cancer Patients and a Mouse Tumor Model.
3/2007	Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ziqiang Yuan Research Topics

Disease

11	Neoplasms (Cancer) 06/2022 - 10/2009
6	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 12/2012
4	Infarction (Infarctions) 01/2021 - 01/2013
4	Carcinogenesis 03/2016 - 09/2004
3	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2007
3	Primitive Neuroectodermal Tumors (PNET) 01/2021 - 12/2012
3	Multiple Endocrine Neoplasia Type 1 01/2019 - 12/2012
3	Myocardial Infarction 05/2014 - 12/2012
2	Fibrosis (Cirrhosis) 01/2021 - 12/2019
2	Adenocarcinoma 01/2018 - 03/2007
2	Lung Neoplasms (Lung Cancer) 01/2018 - 03/2007
2	Retinoblastoma (Glioblastoma, Retinal) 03/2016 - 08/2007
2	Microsatellite Instability 10/2009 - 09/2003
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Infections 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2017
1	Starvation 03/2017
1	AIDS-Related Complex (ARC) 01/2015
1	Insulinoma 12/2012
1	Colonic Neoplasms (Colon Cancer) 10/2009
1	Breast Neoplasms (Breast Cancer) 04/2009
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2007
1	Adenocarcinoma of Lung 03/2007
1	Colorectal Neoplasms (Colorectal Cancer) 01/2006
1	Carcinoma (Carcinomatosis) 09/2004

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2006
4	Messenger RNA (mRNA)IBA 12/2019 - 10/2009
3	Insulin (Novolin)FDA Link 01/2021 - 03/2016
3	Therapeutic UsesIBA 01/2021 - 01/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 03/2016
2	Amino Acids FDA Link 06/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 12/2012
2	ErbB Receptors (EGF Receptor)IBA 10/2009 - 08/2007
2	Complementary DNA (cDNA)IBA 04/2009 - 09/2003
1	Gemcitabine FDA Link 01/2022
1	AntigensIBA 01/2022
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2022
1	Granzymes (Granzyme)IBA 01/2022
1	PerforinIBA 01/2022
1	Hypoxia-Inducible Factor 1IBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 12/2019
1	DNA (Cytosine-5-)-Methyltransferase 1IBA 01/2019
1	Cell-Free Nucleic AcidsIBA 01/2018
1	hydrogen sulfite (bisulfite)IBA 01/2018
1	Phosphorus (Red Phosphorus)IBA 03/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2017
1	Carrier Proteins (Binding Protein)IBA 03/2016
1	1-(1-mercaptocyclohexaneacetic acid)-2-(O- methyl-L-tyrosine)-8-L-arginine- vasopressin (AAVP)IBA 03/2016
1	LigandsIBA 03/2016
1	Peptides (Polypeptides)IBA 03/2016
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2016
1	Octreotide (Sandostatin)FDA LinkGeneric 03/2016
1	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2016
1	Protons (Proton)IBA 11/2015
1	Choline (Choline Chloride)IBA 11/2015
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2012
1	pasireotideIBA 12/2012
1	elisidepsinIBA 08/2011
1	Adenosine (Adenocard)FDA LinkGeneric 10/2009
1	Biomarkers (Surrogate Marker)IBA 04/2009
1	ChemokinesIBA 04/2009
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 08/2007
1	Tyrosine Kinase InhibitorsIBA 08/2007
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2007
1	Cyclin-Dependent Kinase Inhibitor p27IBA 08/2007
1	CyclinsIBA 08/2007
1	Cyclin EIBA 03/2007
1	CopperIBA 01/2006
1	Cyclin D1IBA 09/2004
1	AsbestosIBA 09/2004
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2004

Therapy/Procedure

2	Transplantation 05/2014 - 01/2013
1	Immunotherapy 01/2022
1	Aftercare (After-Treatment) 01/2022
1	Ligation 01/2021
1	Therapeutics 01/2019